Last Price
0.016
Today's Change
0.00 (0.00%)
Day's Change
0.016 - 0.016
Trading Volume
336,397
Market Cap
6 Million
Shares Outstanding
409 Million
Avg Volume
364,198
Avg Price (50 Days)
0.02
Avg Price (200 Days)
0.03
PE Ratio
-0.80
EPS
-0.02
Earnings Announcement
21-Aug-2025
Previous Close
0.02
Open
0.02
Day's Range
0.016 - 0.016
Year Range
0.015 - 0.079
Trading Volume
336,397
1 Day Change
0.00%
5 Day Change
-20.00%
1 Month Change
-15.79%
3 Month Change
-30.43%
6 Month Change
-48.39%
Ytd Change
-51.52%
1 Year Change
-75.76%
3 Year Change
-70.91%
5 Year Change
-89.68%
10 Year Change
-97.56%
Max Change
-98.40%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.
{uid}
{comment}
Just now